Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.

Radwan G, Hecht SS, Carmella SG, Loffredo CA.

Nicotine Tob Res. 2013 Jan;15(1):130-8. doi: 10.1093/ntr/nts099. Epub 2012 May 9.

2.

A comparative study of systemic carcinogen exposure in waterpipe smokers, cigarette smokers and non-smokers.

Al Ali R, Rastam S, Ibrahim I, Bazzi A, Fayad S, Shihadeh AL, Zaatari GS, Maziak W.

Tob Control. 2015 Mar;24(2):125-7. doi: 10.1136/tobaccocontrol-2013-051206. Epub 2013 Aug 29.

3.

Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.

Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS.

J Natl Cancer Inst. 2001 Mar 7;93(5):378-81.

PMID:
11238699
4.

TSNA exposure from cigarette smoking: 18 years of urinary NNAL excretion data.

Appleton S, Olegario RM, Lipowicz PJ.

Regul Toxicol Pharmacol. 2014 Mar;68(2):269-74. doi: 10.1016/j.yrtph.2013.07.013. Epub 2013 Aug 3.

5.

Metabolites of a tobacco-specific carcinogen in urine from newborns.

Lackmann GM, Salzberger U, Töllner U, Chen M, Carmella SG, Hecht SS.

J Natl Cancer Inst. 1999 Mar 3;91(5):459-65.

PMID:
10070946
6.

Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.

Hecht SS, Murphy SE, Carmella SG, Zimmerman CL, Losey L, Kramarczuk I, Roe MR, Puumala SS, Li YS, Le C, Jensen J, Hatsukami DK.

J Natl Cancer Inst. 2004 Jan 21;96(2):107-15.

PMID:
14734700
7.

Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP Jr.

Cancer. 2005 Apr 1;103(7):1420-6.

8.

Urinary NNAL in hookah smokers and non-smokers after attending a hookah social event in a hookah lounge or a private home.

Kassem NOF, Kassem NO, Liles S, Jackson SR, Chatfield DA, Jacob P 3rd, Benowitz NL, Hovell MF.

Regul Toxicol Pharmacol. 2017 Oct;89:74-82. doi: 10.1016/j.yrtph.2017.07.009. Epub 2017 Jul 14.

9.

Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.

Goniewicz ML, Eisner MD, Lazcano-Ponce E, Zielinska-Danch W, Koszowski B, Sobczak A, Havel C, Jacob P, Benowitz NL.

Nicotine Tob Res. 2011 Mar;13(3):202-8. doi: 10.1093/ntr/ntq237. Epub 2011 Jan 21.

10.

Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.

Chen G, Luo S, Kozlovich S, Lazarus P.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1175-1184. doi: 10.1158/1055-9965.EPI-15-1245. Epub 2016 May 9.

11.

Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.

Vardavas CI, Fthenou E, Patelarou E, Bagkeris E, Murphy S, Hecht SS, Connolly GN, Chatzi L, Kogevinas M.

Tob Control. 2013 May;22(3):194-200. doi: 10.1136/tobaccocontrol-2011-050144. Epub 2012 Jan 17.

PMID:
22253001
12.

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone is correlated with 8-hydroxy-2'-deoxyguanosine in humans after exposure to environmental tobacco smoke.

Chiang HC, Huang YK, Chen PF, Chang CC, Wang CJ, Lin P, Lee HL.

Sci Total Environ. 2012 Jan 1;414:134-9. doi: 10.1016/j.scitotenv.2011.11.039. Epub 2011 Dec 3.

PMID:
22138374
13.

Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.

Florek E, Piekoszewski W, Basior A, Merritt AT, Mazela J, Lechowicz W, Kornacka MK, Kramer L.

J Physiol Pharmacol. 2011 Jun;62(3):377-83.

14.

Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homes.

Thomas JL, Guo H, Carmella SG, Balbo S, Han S, Davis A, Yoder A, Murphy SE, An LC, Ahluwalia JS, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1213-21. doi: 10.1158/1055-9965.EPI-10-1027. Epub 2011 Apr 5.

15.

High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.

Carmella SG, Ming X, Olvera N, Brookmeyer C, Yoder A, Hecht SS.

Chem Res Toxicol. 2013 Aug 19;26(8):1209-17. doi: 10.1021/tx400121n. Epub 2013 Jul 24.

16.

[Determination of 4-(methylnirosamino) -4-(3-pyridyl)-1-butanol (NNA) in urine of pregnant women by means of LC/MS/MS].

Florek E, Piekoszewski W, Lechowicz W, Szymańska A, Kornacka MK.

Przegl Lek. 2006;63(10):926-31. Polish.

PMID:
17288186
17.

Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.

Ashley DL, O'Connor RJ, Bernert JT, Watson CH, Polzin GM, Jain RB, Hammond D, Hatsukami DK, Giovino GA, Cummings KM, McNeill A, Shahab L, King B, Fong GT, Zhang L, Xia Y, Yan X, McCraw JM.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1389-98. doi: 10.1158/1055-9965.EPI-10-0084. Epub 2010 May 25. Erratum in: Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2416.

18.

Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.

Xia Y, Bernert JT, Jain RB, Ashley DL, Pirkle JL.

Biomarkers. 2011 Mar;16(2):112-9. doi: 10.3109/1354750X.2010.533288. Epub 2010 Nov 29.

PMID:
21114376
19.

Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.

Hou H, Zhang X, Tian Y, Tang G, Liu Y, Hu Q.

J Pharm Biomed Anal. 2012 Apr 7;63:17-22. doi: 10.1016/j.jpba.2012.01.028. Epub 2012 Jan 30.

PMID:
22366322
20.

Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.

Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):521-5.

Supplemental Content

Support Center